<DOC>
	<DOCNO>NCT01347294</DOCNO>
	<brief_summary>The purpose study determine effectiveness bleomycin , fibrovein bleomycin fibrovein treatment venous malformation .</brief_summary>
	<brief_title>Compare Two Different Sclerosing Agents Treatment Venous Malformations</brief_title>
	<detailed_description>Patients scanty symptom vascular malformation well conservative treatment / aid adaptation daily life . Compression therapy ( elastic stocking ) , pain medication good counseling adequate many . Patients significant symptom , however , may require invasive treatment . Previously , common surgical removal , serious sequela frequent recurrence surgery result caution . Today common intervention radiology treatment injection sclerosing agent exist malformation . This type therapy almost always require repeated treatment sequence , sometimes several month . Treatment aim seal blood vessel malformation / make patient possible symptom . Recurrence occur frequently many completely free symptom . Many patient chronic problem pain , wound , bleed / cosmetically disfigure condition . Predicting performance specific type treatment difficult . Until , study consider effect bleomycin / pingyangmycin ( China ) ethanol treatment vascular malformation . To knowledge prospective retrospective study compare efficacy side effect bleomycin sodium tetradecyl sulfate ( Fibrovein â„¢ ) treatment VM .</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>Venous malformation kidney lung disease</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>